175 related articles for article (PubMed ID: 9221850)
1. Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial.
Sanz-Altamira PM; Spence LD; Huberman MS; Posner MR; Steele G; Perry LJ; Stuart KE
Dis Colon Rectum; 1997 Jul; 40(7):770-5. PubMed ID: 9221850
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy.
Abramson RG; Rosen MP; Perry LJ; Brophy DP; Raeburn SL; Stuart KE
Radiology; 2000 Aug; 216(2):485-91. PubMed ID: 10924575
[TBL] [Abstract][Full Text] [Related]
3. Colorectal metastases to the liver: selective chemoembolization.
Lang EK; Brown CL
Radiology; 1993 Nov; 189(2):417-22. PubMed ID: 8210369
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization for hepatocellular carcinoma: epinephrine followed by a doxorubicin-ethiodized oil emulsion and gelatin sponge powder.
Clouse ME; Stokes KR; Kruskal JB; Perry LJ; Stuart KE; Nasser IA
J Vasc Interv Radiol; 1993; 4(6):717-25. PubMed ID: 7506597
[TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase II trial of embolization therapy versus chemoembolization therapy in previously treated patients with colorectal carcinoma metastatic to the liver.
Salman HS; Cynamon J; Jagust M; Bakal C; Rozenblit A; Kaleya R; Negassa A; Wadler S
Clin Colorectal Cancer; 2002 Nov; 2(3):173-9. PubMed ID: 12482334
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature.
Tellez C; Benson AB; Lyster MT; Talamonti M; Shaw J; Braun MA; Nemcek AA; Vogelzang RL
Cancer; 1998 Apr; 82(7):1250-9. PubMed ID: 9529016
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hepatocellular carcinoma using doxorubicin/ethiodized oil/gelatin powder chemoembolization.
Stuart K; Stokes K; Jenkins R; Trey C; Clouse M
Cancer; 1993 Dec; 72(11):3202-9. PubMed ID: 7694787
[TBL] [Abstract][Full Text] [Related]
10. Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome.
Miyayama S; Matsui O
J Vasc Interv Radiol; 2016 Sep; 27(9):1269-1278. PubMed ID: 27345337
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors.
Clouse ME; Perry L; Stuart K; Stokes KR
Digestion; 1994; 55 Suppl 3():92-7. PubMed ID: 7698544
[TBL] [Abstract][Full Text] [Related]
12. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
13. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).
Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR
Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207
[TBL] [Abstract][Full Text] [Related]
14. Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience.
Gupta S; Yao JC; Ahrar K; Wallace MJ; Morello FA; Madoff DC; Murthy R; Hicks ME; Ajani JA
Cancer J; 2003; 9(4):261-7. PubMed ID: 12967136
[TBL] [Abstract][Full Text] [Related]
15. Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma.
Martinelli DJ; Wadler S; Bakal CW; Cynamon J; Rozenblit A; Haynes H; Kaleya R; Wiernik PH
Cancer; 1994 Sep; 74(6):1706-12. PubMed ID: 8082071
[TBL] [Abstract][Full Text] [Related]
16. Chemoembolization in liver malignant involvement. Experiences on 17 cases.
Fiorentini G; Campanini A; Dazzi C; Davitti B; Graziani G; Priori T; Ricci Bitti R; Angelini L
Minerva Chir; 1994 Apr; 49(4):281-5. PubMed ID: 8072703
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency.
Geschwind JF; Ramsey DE; Cleffken B; van der Wal BC; Kobeiter H; Juluru K; Hartnell GG; Choti MA
Cardiovasc Intervent Radiol; 2003; 26(2):111-7. PubMed ID: 12616414
[TBL] [Abstract][Full Text] [Related]
18. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.
Winkelbauer FW; Niederle B; Pietschmann F; Thurnher S; Wildling R; Prokesch R; Lammer J
AJR Am J Roentgenol; 1995 Aug; 165(2):323-7. PubMed ID: 7542430
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of hepatic artery infusion therapy for hepatic metastases from colorectal carcinoma after radiological placement of infusion catheters.
Sameshima S; Horikoshi H; Motegi K; Tomozawa S; Hirayama I; Saito T; Sawada T
Eur J Surg Oncol; 2007 Aug; 33(6):741-5. PubMed ID: 17399936
[TBL] [Abstract][Full Text] [Related]
20. Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
Leichman CG; Jacobson JR; Modiano M; Daniels JR; Zalupski MM; Doroshow JH; Fletcher WS; Macdonald JS
Cancer; 1999 Sep; 86(5):775-81. PubMed ID: 10463975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
